Differences between revisions 2 and 3
Revision 2 as of 2012-09-06 21:56:10
Size: 914
Editor: KeiichiroOno
Comment:
Revision 3 as of 2012-09-07 13:09:58
Size: 1192
Editor: server2
Comment:
Deletions are marked like this. Additions are marked like this.
Line 6: Line 6:
|| Mac OS 10.8.1 || Apple JDK 1.6.0_33 || Yes || 6-Sep-2013 || 1 ||
|| Mac OS 10.8.1 || Oracle JDK SE 7u7 || || || 1 ||
|| Mac OS 10.8.1 || Apple JDK 1.6.0_33 || Yes || 6-Sep-2013 || 1, 2 ||
|| || Oracle JDK SE 7u7 || || || 1, 2 ||
Line 9: Line 9:
|| Mac OS 10.7 || Oracle JDK SE 7u7 || || || 1 || || || Oracle JDK SE 7u7 || || || 1 ||
Line 19: Line 19:
1. Haven't tested installer on this platform yet.  1. Haven't tested installer on this platform yet.
 2. The default Gatekeeper settings cause an error saying the DMG is damaged. We need to sign our installer DMG somehow to avoid this. Users can work around this by disabling Gatekeeper temporarily (System Preferences → Security & Privacy → Allow applications downloaded from → Anywhere)

Compatibility

This page summarizes the platforms Cytoscape 3 has been tested on and any workarounds that need to be done to get it to install and launch.

OS

JDK/JRE

Compatible?

Last Tested

Notes

Mac OS 10.8.1

Apple JDK 1.6.0_33

Yes

6-Sep-2013

1, 2

Oracle JDK SE 7u7

1, 2

Mac OS 10.7

Apple JDK 1.6.0_33

1

Oracle JDK SE 7u7

1

Mac OS 10.6

1

Mac OS 10.5

1

Windows 8 64-bit

JRE 1.7.0_05

Yes

6-Sep-2013

1

Windows 8 32-bit

1

Windows 7 64-bit

JRE 1.7.0_02

Yes

6-Sep-2013

1

Windows 7 32-bit

1

Ubuntu Desktop 12.04 LTS amd64

Oracle JDK SE 7u7

1

Ubuntu Desktop 11.10 amd64

Oracle JDK SE 7u7

1

  1. Haven't tested installer on this platform yet.
  2. The default Gatekeeper settings cause an error saying the DMG is damaged. We need to sign our installer DMG somehow to avoid this. Users can work around this by disabling Gatekeeper temporarily (System Preferences → Security & Privacy → Allow applications downloaded from → Anywhere)

Cytoscape_3/Compatibility (last edited 2012-09-07 22:15:15 by server2)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux